It has been shown that IGFBP-3 inhibits the growth of the IGF-unresponsive Hs578 human breast cancer cell line [8,16] and enhances the effects of ceramide and paclitaxol-induced apoptosis directly [7,29]. This evidence concerns the gene IGF1 and breast cancer.